85 related articles for article (PubMed ID: 20367265)
1. Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-bone interactions and potential targeted therapeutics.
Jayanthan A; Miettunen PM; Incoronato A; Ortiz-Neira CL; Lewis VA; Anderson R; Frohlich DE; Narendran A
Pediatr Hematol Oncol; 2010 Apr; 27(3):212-27. PubMed ID: 20367265
[TBL] [Abstract][Full Text] [Related]
2. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
4. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.
Barr RD; Guo CY; Wiernikowski J; Webber C; Wright M; Atkinson S
Med Pediatr Oncol; 2002 Jul; 39(1):44-6. PubMed ID: 12116079
[No Abstract] [Full Text] [Related]
5. Delayed diagnosis of acute leukemia in a patient with bone pain and fracture.
Oztürkmen S; Akyay A; Biçakçi Z; Karakoç Y; Arikan SM; Celebi-Tayfur A; Ağladioğlu S; Olcay L
Turk J Pediatr; 2010; 52(5):552-5. PubMed ID: 21434546
[TBL] [Abstract][Full Text] [Related]
6. [Pediatric acute lymphoblastic leukemia initially presenting with bone marrow necrosis].
Kato M; Kikuchi A; Oshima K; Yamamoto S; Mochizuki S; Arai K; Hanada R
Rinsho Ketsueki; 2007 Feb; 48(2):140-3. PubMed ID: 17370642
[TBL] [Abstract][Full Text] [Related]
7. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
8. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.
Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I
Arch Immunol Ther Exp (Warsz); 2005; 53(4):357-63. PubMed ID: 16088321
[TBL] [Abstract][Full Text] [Related]
9. Severe hypercalcemia: A rare and unusual presentation of acute lymphoblastic leukemia.
Dhivyasree S; Dhivyalakshmi J; Sankaranarayanan S; Scott JX
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1244-S1246. PubMed ID: 30539882
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
11. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
[TBL] [Abstract][Full Text] [Related]
12. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
[TBL] [Abstract][Full Text] [Related]
14. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia.
Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K
Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231
[TBL] [Abstract][Full Text] [Related]
15. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study.
Dubansky AS; Boyett JM; Falletta J; Mahoney DH; Land VJ; Pullen J; Buchanan G
Pediatrics; 1989 Dec; 84(6):1068-71. PubMed ID: 2587136
[TBL] [Abstract][Full Text] [Related]
16. Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
Kitszel A; Krawczuk-Rybak M
Adv Med Sci; 2007; 52():147-53. PubMed ID: 18217408
[TBL] [Abstract][Full Text] [Related]
17. Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia.
von Lintig FC; Huvar I; Law P; Diccianni MB; Yu AL; Boss GR
Clin Cancer Res; 2000 May; 6(5):1804-10. PubMed ID: 10815901
[TBL] [Abstract][Full Text] [Related]
18. Typhlitis in a patient with acute lymphoblastic leukemia prior to the administration of chemotherapy.
Paulino AF; Kenney R; Forman EN; Medeiros LJ
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):348-51. PubMed ID: 7978054
[TBL] [Abstract][Full Text] [Related]
19. My aching bones: skeletal complications of acute lymphoblastic leukemia.
Nachman JB
Pediatr Blood Cancer; 2006 Jan; 46(1):1. PubMed ID: 16261585
[No Abstract] [Full Text] [Related]
20. Acute lymphoblastic leukemia presented as severe jaundice and hyperferritinemia: a case report.
Chang LS; Yu HR; Chen YC; Yeah ST; Tiao MM; Hsiao CC; Sheen JM
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e117-9. PubMed ID: 21368676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
